130 related articles for article (PubMed ID: 9841710)
1. X-linked lymphoproliferative disease: pathology and diagnosis.
Maia DM; Garwacki CP
Pediatr Dev Pathol; 1999; 2(1):72-7. PubMed ID: 9841710
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
[TBL] [Abstract][Full Text] [Related]
3. [X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies].
Schuster V; Grimm T; Kress W; Seidenspinner S; Belohradsky BH; Müller P; Kreth HW
Klin Padiatr; 1995; 207(5):271-6. PubMed ID: 7500602
[TBL] [Abstract][Full Text] [Related]
4. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of the X-linked lymphoproliferative syndrome.
Purtilo DT
Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
7. X-linked lymphoproliferative syndrome.
Sullivan JL; Woda BA
Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
Tatsumi E; Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
[TBL] [Abstract][Full Text] [Related]
9. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated lymphoproliferative disorder with fatal involvement of the gastrointestinal tract in an infant.
Pan LX; Ramani P; Diss TC; Liang LN; Isaacson PG
J Clin Pathol; 1995 Apr; 48(4):390-2. PubMed ID: 7615866
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.
Purtilo DT; Sakamoto K; Barnabei V; Seeley J; Bechtold T; Rogers G; Yetz J; Harada S
Am J Med; 1982 Jul; 73(1):49-56. PubMed ID: 6283885
[TBL] [Abstract][Full Text] [Related]
12. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
13. A boy with fatal infectious mononucleosis suspected as the first Japanese case of X-linked lymphoproliferative syndrome.
Tsutsumi H; Kamazaki H; Satoh M; Imai S; Nakata S; Chiba S
Scand J Infect Dis; 1998; 30(6):610-2. PubMed ID: 10225392
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders.
Iwatsuki K; Ohtsuka M; Harada H; Han G; Kaneko F
Arch Dermatol; 1997 Sep; 133(9):1081-6. PubMed ID: 9301584
[TBL] [Abstract][Full Text] [Related]
15. Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.
Malbran A; Belmonte L; Ruibal-Ares B; Baré P; Massud I; Parodi C; Felippo M; Hodinka R; Haines K; Nichols KE; de Bracco MM
Blood; 2004 Mar; 103(5):1625-31. PubMed ID: 14604960
[TBL] [Abstract][Full Text] [Related]
16. Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP).
Sanger WG; Grierson HL; Skare J; Wyandt H; Pirruccello S; Fordyce R; Purtilo DT
Cancer Genet Cytogenet; 1990 Jul; 47(2):163-9. PubMed ID: 1972651
[TBL] [Abstract][Full Text] [Related]
17. Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.
Salama ME; Parham DM; Perkins SL; Bahler DW; Ellison DA
Pediatr Dev Pathol; 2008; 11(6):443-9. PubMed ID: 18473605
[TBL] [Abstract][Full Text] [Related]
18. Methods of detection of new families with X-linked lymphoproliferative disease.
Purtilo DT; Grierson HL
Cancer Genet Cytogenet; 1991 Feb; 51(2):143-53. PubMed ID: 1847089
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome.
Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
Pathol Int; 1998 Dec; 48(12):934-43. PubMed ID: 9952337
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience.
Rogers BB; Sommerauer J; Quan A; Timmons CF; Dawson DB; Scheuermann RH; Krisher K; Atkins C
Pediatr Dev Pathol; 1998; 1(6):480-6. PubMed ID: 9724334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
